Statera Managing Agency Limited has received regulatory approval to operate as a Lloyd's managing agent, a move that brings the management of Syndicates 4242 and 1416 fully in-house.
The two syndicates underwrite a range of specialty risks sourced through Octave Ventures, a division of Octave Specialty Group. Both benefit from Lloyd's A+ financial strength rating, its extensive global licensing network and access to capital from an investor base that includes reinsurers, high-net-worth individuals and its institutional investors. This structure allows the syndicates to deploy capital flexibly across international specialty lines where Lloyd's remains a key market.
Previously, Asta Managing Agency Limited acted as managing agent for the syndicates, while Octave Ventures set underwriting strategy and handled day-to-day operations under a management agreement. The creation of Statera as a Lloyd’s-approved managing agent brings those responsibilities under a single governance and operating framework, reducing reliance on third-party providers and centralising oversight of underwriting, compliance and capital management.
Scott Fordham, chief executive officer of Statera, said the approval formalises a role the business has effectively been performing for some time. He said that becoming a Lloyd’s managing agent enhances Statera’s ability to add value to the market, and that the transition is expected to be seamless given Octave Ventures already provides much of the infrastructure supporting the syndicates.
The Lloyd's market has seen a broad shift where underwriting groups with established scale and track records are increasingly seeking managing agent status to gain greater strategic control. Since Lloyd's market reforms following the pandemic, there has been a stronger focus on profitability, disciplined growth and alignment between underwriting performance and capital deployment.
Bringing managing agency functions in-house is seen by many groups as a way to improve efficiency, strengthen governance and accelerate decision-making, the company said.
For Lloyd's, the approval of Statera adds another specialist managing agent that supports the market's aim to attract high-quality risks and diverse sources of capital. For brokers and insureds, the immediate impact is expected to be limited, with no material change to underwriting appetite or operational processes in the near term. Over time, however, the consolidated structure could support faster product development, clearer accountability and closer alignment between underwriting teams and capital providers.
More broadly, Statera’s approval highlights the continued appeal of the Lloyd’s platform for specialty insurers seeking global reach, regulatory certainty and access to a deep and varied capital base in an increasingly competitive international insurance market.
